We are live on ! Find out more
LENZ

LENZ Therapeutics
LENZ

58 hedge funds and large institutions have $432M invested in LENZ Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.3% less ownership

Funds ownership: 8.85% → 8.54% (-0.3%)

3% less funds holding

Funds holding: 60 → 58 (-2)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

27% less capital invested

Capital invested by funds: $587M → $432M (-$156M)

Holders
58
Holders Change
-2
Holders Change %
-3.33%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
25
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$8.15M
2
SB
Samsara BioCapital
California
+$4.97M
3
Morgan Stanley
Morgan Stanley
New York
+$3.37M
4
BlackRock
BlackRock
New York
+$3.11M
5
SFM
Sphera Funds Management
Israel
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$15.2M
2
DM
Deerfield Management
New York
-$14.9M
3
LGM
Logos Global Management
California
-$9.47M
4
Millennium Management
Millennium Management
New York
-$4.91M
5
Jennison Associates
Jennison Associates
New York
-$4.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.06M +$263K +3,174 +16%
Millennium Management
27
Millennium Management
New York
$1.57M -$4.91M -59,206 -77%
E
28
Ergoteles
New York
$897K +$854K +10,308 New
Bank of America
29
Bank of America
North Carolina
$824K +$423K +5,111 +117%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$569K +$75.6K +912 +16%
Charles Schwab
31
Charles Schwab
California
$530K +$33.3K +402 +7%
Jane Street
32
Jane Street
New York
$520K +$495K +5,980 New
JG
33
Jefferies Group
New York
$374K +$356K +4,296 New
Goldman Sachs
34
Goldman Sachs
New York
$247K -$642K -7,745 -73%
N
35
Nuveen
North Carolina
$240K -$127K -1,538 -31%
VEA
36
Virtus ETF Advisers
New York
$197K +$188K +2,265 New
CAN
37
Cetera Advisor Networks
California
$179K +$35.5K +428 +26%
CSS
38
Cubist Systematic Strategies
Connecticut
$167K +$55.9K +675 +54%
Wells Fargo
39
Wells Fargo
California
$160K +$118K +1,423 +337%
ProShare Advisors
40
ProShare Advisors
Maryland
$147K +$139K +1,676 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$145K -$746 -9 -0.5%
JP Morgan Chase
42
JP Morgan Chase
New York
$141K +$60.6K +732 +82%
Deutsche Bank
43
Deutsche Bank
Germany
$123K +$6.05K +73 +5%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$109K +$249 +3 +0.2%
AIG
45
American International Group
New York
$107K -$2.98K -36 -3%
UBS Group
46
UBS Group
Switzerland
$98K +$63.6K +768 +215%
Allspring Global Investments
47
Allspring Global Investments
North Carolina
$83K +$79.5K +959 New
TRCT
48
Tower Research Capital (TRC)
New York
$74K +$62.6K +755 +778%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$73K +$1.66K +20 +2%
Citigroup
50
Citigroup
New York
$72K +$46.3K +559 +207%
1
2
3

LENZ Hedge Fund Activity: Q4 2021 in Review

58 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in LENZ Therapeutics (LENZ) for Q4 2021, worth a combined $432M — down 27% from $587M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of LENZ and 9 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 25 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $8.15M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $15.2M sold.

  • 58 institutional investors held LENZ Therapeutics (LENZ) as of Q4 2021, down from 60 in Q3 2021.
  • Funds reported $432M of LENZ Therapeutics stock for Q4 2021, down 27% quarter-over-quarter.
  • 9 funds opened new LENZ Therapeutics positions in Q4 2021 and 11 closed out, a net change of -2 holders.
  • The largest LENZ Therapeutics buyer in Q4 2021 was EcoR1 Capital, an estimated $8.15M added.
  • The largest LENZ Therapeutics seller in Q4 2021 was Janus Henderson Group, an estimated $15.2M sold.

Based on aggregated 13F filings for Q4 2021.